EpimAb nabs Bin Peng from NI­BR; Jef­frey Chodake­witz ex­its Ver­tex; Chris­tiana Sta­moulis is pres­i­dent at Unum

Chris­tiana Sta­moulis is get­ting busier at Unum Ther­a­peu­tics as she adds the role of pres­i­dent to her CFO and head of cor­po­rate de­vel­op­ment du­ties. She will now be re­spon­si­ble for many of the im­munother­a­py com­pa­ny’s func­tions, in­clud­ing cor­po­rate strat­e­gy, le­gal, in­vestor re­la­tions and com­mu­ni­ca­tions. A for­mer in­vest­ment banker and Ver­tex ex­ec, Sta­moulis was cred­it­ed for head­ing Unum’s $65 mil­lion se­ries B and its part­ner­ship with Seat­tle Ge­net­ics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.